Innovative Dual mRNA-Lipid Nanoparticle Therapy Targeting CRHBP and CFHR3 for Enhanced Treatment of Hepatocellular Carcinoma
Tianmei Fu,1,* Boxuan Zhou,2,* Yingliang Li,2,* Wei Liu,1 Yuankang Xie,3 Zhaohong Mo,4 Fang Yin,1 Yu Wang,1 Kang Fang,5 Yangyang Fang,1 Ziqing Xiong,1 Kuai Yu,1 Aiping Le1 1Department of Transfusion Medicine, Key Laboratory of Jiangxi Province for Transfusion Medicine, The Fi...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2024-12-01
|
| Series: | International Journal of Nanomedicine |
| Subjects: | |
| Online Access: | https://www.dovepress.com/innovative-dual-mrna-lipid-nanoparticle-therapy-targeting-crhbp-and-cf-peer-reviewed-fulltext-article-IJN |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846136662108667904 |
|---|---|
| author | Fu T Zhou B Li Y Liu W Xie Y Mo Z Yin F Wang Y Fang K Fang Y Xiong Z Yu K Le A |
| author_facet | Fu T Zhou B Li Y Liu W Xie Y Mo Z Yin F Wang Y Fang K Fang Y Xiong Z Yu K Le A |
| author_sort | Fu T |
| collection | DOAJ |
| description | Tianmei Fu,1,* Boxuan Zhou,2,* Yingliang Li,2,* Wei Liu,1 Yuankang Xie,3 Zhaohong Mo,4 Fang Yin,1 Yu Wang,1 Kang Fang,5 Yangyang Fang,1 Ziqing Xiong,1 Kuai Yu,1 Aiping Le1 1Department of Transfusion Medicine, Key Laboratory of Jiangxi Province for Transfusion Medicine, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People’s Republic of China; 2Department of Breast Disease Center, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People’s Republic of China; 3Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Gannan Medical University, Ganzhou, People’s Republic of China; 4Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanchang, People’s Republic of China; 5Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People’s Republic of China*These authors contributed equally to this workCorrespondence: Kuai Yu; Aiping Le, Email yukuai1949@foxmail.com; ndyfy00973@ncu.edu.cnPurpose: Hepatocellular carcinoma (HCC) is a deadly disease requiring the identification of new therapeutic targets and strategies.Methods: This study identified genes linked to HCC progression via differential analysis. Key genes were identified through univariate and multivariate Cox regression analysis. The biological effects of co-expressed CRHBP and CFHR3 were evaluated in vitro. mRNAs encoding CRHBP and CFHR3 were encapsulated in lipid nanoparticles (LNPs), with the addition of SP94 peptide on the LNPs surface to enhance targeting. The therapeutic efficacy of dual-mRNA LNPs was evaluated in HCC cells and mouse models.Results: CRHBP and CFHR3 were closely associated with HCC progression. Low expression of CRHBP (P < 0.01, HR = 1.931 [1.174– 3.175]) and CFHR3 (P < 0.05, HR = 1.755 [1.066– 2.890]) was identified as a poor prognostic factor for HCC. The risk score model combining CRHBP and CFHR3 demonstrated superior predictive power (P < 0.001, HR = 2.935 [1.768– 4.872]). Co-expression of CRHBP and CFHR3 significantly inhibited the malignant biological functions of HCC cells. Treatment with SP94 peptide-modified dual-mRNA LNPs markedly suppressed HCC tumor growth and exhibited excellent biocompatibility and safety.Conclusion: Our study proposes a dual-targeted therapeutic strategy for HCC, which may represent a promising treatment approach. Keywords: CRHBP, CFHR3, Lipid nanoparticles, mRNA |
| format | Article |
| id | doaj-art-4e4f724affd3410ba929b6967da5fef4 |
| institution | Kabale University |
| issn | 1178-2013 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | International Journal of Nanomedicine |
| spelling | doaj-art-4e4f724affd3410ba929b6967da5fef42024-12-08T17:58:38ZengDove Medical PressInternational Journal of Nanomedicine1178-20132024-12-01Volume 19131831319998099Innovative Dual mRNA-Lipid Nanoparticle Therapy Targeting CRHBP and CFHR3 for Enhanced Treatment of Hepatocellular CarcinomaFu TZhou BLi YLiu WXie YMo ZYin FWang YFang KFang YXiong ZYu KLe ATianmei Fu,1,* Boxuan Zhou,2,* Yingliang Li,2,* Wei Liu,1 Yuankang Xie,3 Zhaohong Mo,4 Fang Yin,1 Yu Wang,1 Kang Fang,5 Yangyang Fang,1 Ziqing Xiong,1 Kuai Yu,1 Aiping Le1 1Department of Transfusion Medicine, Key Laboratory of Jiangxi Province for Transfusion Medicine, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People’s Republic of China; 2Department of Breast Disease Center, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People’s Republic of China; 3Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Gannan Medical University, Ganzhou, People’s Republic of China; 4Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanchang, People’s Republic of China; 5Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People’s Republic of China*These authors contributed equally to this workCorrespondence: Kuai Yu; Aiping Le, Email yukuai1949@foxmail.com; ndyfy00973@ncu.edu.cnPurpose: Hepatocellular carcinoma (HCC) is a deadly disease requiring the identification of new therapeutic targets and strategies.Methods: This study identified genes linked to HCC progression via differential analysis. Key genes were identified through univariate and multivariate Cox regression analysis. The biological effects of co-expressed CRHBP and CFHR3 were evaluated in vitro. mRNAs encoding CRHBP and CFHR3 were encapsulated in lipid nanoparticles (LNPs), with the addition of SP94 peptide on the LNPs surface to enhance targeting. The therapeutic efficacy of dual-mRNA LNPs was evaluated in HCC cells and mouse models.Results: CRHBP and CFHR3 were closely associated with HCC progression. Low expression of CRHBP (P < 0.01, HR = 1.931 [1.174– 3.175]) and CFHR3 (P < 0.05, HR = 1.755 [1.066– 2.890]) was identified as a poor prognostic factor for HCC. The risk score model combining CRHBP and CFHR3 demonstrated superior predictive power (P < 0.001, HR = 2.935 [1.768– 4.872]). Co-expression of CRHBP and CFHR3 significantly inhibited the malignant biological functions of HCC cells. Treatment with SP94 peptide-modified dual-mRNA LNPs markedly suppressed HCC tumor growth and exhibited excellent biocompatibility and safety.Conclusion: Our study proposes a dual-targeted therapeutic strategy for HCC, which may represent a promising treatment approach. Keywords: CRHBP, CFHR3, Lipid nanoparticles, mRNAhttps://www.dovepress.com/innovative-dual-mrna-lipid-nanoparticle-therapy-targeting-crhbp-and-cf-peer-reviewed-fulltext-article-IJNcrhbpcfhr3lipid nanoparticlesmrna |
| spellingShingle | Fu T Zhou B Li Y Liu W Xie Y Mo Z Yin F Wang Y Fang K Fang Y Xiong Z Yu K Le A Innovative Dual mRNA-Lipid Nanoparticle Therapy Targeting CRHBP and CFHR3 for Enhanced Treatment of Hepatocellular Carcinoma International Journal of Nanomedicine crhbp cfhr3 lipid nanoparticles mrna |
| title | Innovative Dual mRNA-Lipid Nanoparticle Therapy Targeting CRHBP and CFHR3 for Enhanced Treatment of Hepatocellular Carcinoma |
| title_full | Innovative Dual mRNA-Lipid Nanoparticle Therapy Targeting CRHBP and CFHR3 for Enhanced Treatment of Hepatocellular Carcinoma |
| title_fullStr | Innovative Dual mRNA-Lipid Nanoparticle Therapy Targeting CRHBP and CFHR3 for Enhanced Treatment of Hepatocellular Carcinoma |
| title_full_unstemmed | Innovative Dual mRNA-Lipid Nanoparticle Therapy Targeting CRHBP and CFHR3 for Enhanced Treatment of Hepatocellular Carcinoma |
| title_short | Innovative Dual mRNA-Lipid Nanoparticle Therapy Targeting CRHBP and CFHR3 for Enhanced Treatment of Hepatocellular Carcinoma |
| title_sort | innovative dual mrna lipid nanoparticle therapy targeting crhbp and cfhr3 for enhanced treatment of hepatocellular carcinoma |
| topic | crhbp cfhr3 lipid nanoparticles mrna |
| url | https://www.dovepress.com/innovative-dual-mrna-lipid-nanoparticle-therapy-targeting-crhbp-and-cf-peer-reviewed-fulltext-article-IJN |
| work_keys_str_mv | AT fut innovativedualmrnalipidnanoparticletherapytargetingcrhbpandcfhr3forenhancedtreatmentofhepatocellularcarcinoma AT zhoub innovativedualmrnalipidnanoparticletherapytargetingcrhbpandcfhr3forenhancedtreatmentofhepatocellularcarcinoma AT liy innovativedualmrnalipidnanoparticletherapytargetingcrhbpandcfhr3forenhancedtreatmentofhepatocellularcarcinoma AT liuw innovativedualmrnalipidnanoparticletherapytargetingcrhbpandcfhr3forenhancedtreatmentofhepatocellularcarcinoma AT xiey innovativedualmrnalipidnanoparticletherapytargetingcrhbpandcfhr3forenhancedtreatmentofhepatocellularcarcinoma AT moz innovativedualmrnalipidnanoparticletherapytargetingcrhbpandcfhr3forenhancedtreatmentofhepatocellularcarcinoma AT yinf innovativedualmrnalipidnanoparticletherapytargetingcrhbpandcfhr3forenhancedtreatmentofhepatocellularcarcinoma AT wangy innovativedualmrnalipidnanoparticletherapytargetingcrhbpandcfhr3forenhancedtreatmentofhepatocellularcarcinoma AT fangk innovativedualmrnalipidnanoparticletherapytargetingcrhbpandcfhr3forenhancedtreatmentofhepatocellularcarcinoma AT fangy innovativedualmrnalipidnanoparticletherapytargetingcrhbpandcfhr3forenhancedtreatmentofhepatocellularcarcinoma AT xiongz innovativedualmrnalipidnanoparticletherapytargetingcrhbpandcfhr3forenhancedtreatmentofhepatocellularcarcinoma AT yuk innovativedualmrnalipidnanoparticletherapytargetingcrhbpandcfhr3forenhancedtreatmentofhepatocellularcarcinoma AT lea innovativedualmrnalipidnanoparticletherapytargetingcrhbpandcfhr3forenhancedtreatmentofhepatocellularcarcinoma |